Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Takara Bio Inc. ( (JP:4974) ) has provided an announcement.
Takara Bio Inc. has announced its relationship with its parent company, Takara Holdings Inc., highlighting its operational independence within the group. Despite being part of a larger corporate structure, Takara Bio Inc. maintains autonomy in its business operations, reporting to Takara Holdings Inc. without requiring prior approval for board resolutions. This structure aims to maximize corporate value while ensuring the company’s growth and independence.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen830.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc. is a company specializing in the biotechnology industry, operating as a subsidiary within the Takara Holdings Group. The company focuses on biotechnology products and services, leveraging its position within a larger group of 70 companies, including 68 subsidiaries and two affiliates, to enhance growth and competitiveness in its sector.
Average Trading Volume: 228,946
Technical Sentiment Signal: Sell
Current Market Cap: Yen94.17B
See more insights into 4974 stock on TipRanks’ Stock Analysis page.